Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance
出版年份 2021 全文链接
标题
Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance
作者
关键词
-
出版物
Nature Communications
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-17
DOI
10.1038/s41467-021-24108-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex–mediated STAT1 downregulation
- (2020) Xiaoyan Zhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Oxidative Stress in Cancer
- (2020) John D. Hayes et al. CANCER CELL
- Cancer Stem Cells: The Architects of the Tumor Ecosystem
- (2019) Briana C. Prager et al. Cell Stem Cell
- Challenges to curing primary brain tumours
- (2019) Kenneth Aldape et al. Nature Reviews Clinical Oncology
- Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance
- (2018) Nobuaki Takahashi et al. CANCER CELL
- Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells
- (2018) Jianghong Man et al. Cell Stem Cell
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- Reactive oxygen species and cancer paradox: To promote or to suppress?
- (2017) Sehamuddin Galadari et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
- (2017) Xun Jin et al. NATURE MEDICINE
- Purine synthesis promotes maintenance of brain tumor initiating cells in glioma
- (2017) Xiuxing Wang et al. NATURE NEUROSCIENCE
- Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor
- (2016) Shintaro Iwasaki et al. NATURE
- Mitochondrial ROS Signaling in Organismal Homeostasis
- (2015) Gerald S. Shadel et al. CELL
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Unravelling tumour heterogeneity—implications for therapy
- (2015) David A. Reardon et al. Nature Reviews Clinical Oncology
- A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation
- (2015) Cristina Moncunill-Massaguer et al. Oncotarget
- Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin
- (2015) WEI CHEN et al. Molecular Medicine Reports
- Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
- (2014) Mario L. Suvà et al. CELL
- ROS Function in Redox Signaling and Oxidative Stress
- (2014) Michael Schieber et al. CURRENT BIOLOGY
- Stem cells and the impact of ROS signaling
- (2014) C. L. Bigarella et al. DEVELOPMENT
- Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
- (2014) Li Pan et al. NATURAL PRODUCT REPORTS
- RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
- (2014) Andrew L. Wolfe et al. NATURE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress
- (2013) H C Whitaker et al. BRITISH JOURNAL OF CANCER
- Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
- (2013) Frédéric Thuaud et al. CHEMISTRY & BIOLOGY
- Expression of prohibitins on the surface of activated T cells
- (2012) Hajime Yurugi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2
- (2012) Gernot Polier et al. CHEMISTRY & BIOLOGY
- Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane
- (2012) C-F Chiu et al. ONCOGENE
- The role and therapeutic potential of prohibitin in disease
- (2011) Arianne L. Theiss et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Signal transduction by reactive oxygen species
- (2011) Toren Finkel JOURNAL OF CELL BIOLOGY
- Regulation of reactive oxygen species in stem cells and cancer stem cells
- (2011) Chiharu I. Kobayashi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Reactive oxygen species, cellular redox systems, and apoptosis
- (2010) Magdalena L. Circu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling
- (2009) Andrew G. Cox et al. BIOCHEMICAL JOURNAL
- Prohibitins and the functional compartmentalization of mitochondrial membranes
- (2009) C. Osman et al. JOURNAL OF CELL SCIENCE
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Prohibitin and mitochondrial biology
- (2009) Marta Artal-Sanz et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria
- (2008) C. Merkwirth et al. GENES & DEVELOPMENT
- Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence
- (2008) Michael Schleicher et al. JOURNAL OF CELL BIOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started